Giants Pfizer, ShineCapital, and Balaji Join Forces for VitaDAO Fundraiser: A Game-Changer for the DAO Ecosystem A DAOstruct Take!

VitaDAO, the trailblazing decentralized autonomous organization that's revolutionizing the way we fund research in the field of longevity science, has secured a major victory with its recent $4.1 million raise. The round was led by the venture arm of none other than Pfizer , a true giant in the pharmaceutical industry,  venture fund Shine Capital , investment firm L1 Digital AG , decentralized science organizations BeakerDAO and Spaceship DAO, as well as prominent individuals in the longevity field like former Coinbase  CTO Balaji Srinivasan and Retro Biosciences' Joe Betts-LaCroix. Notable previous investors in VitaDAO include Ethereum  co-founder Vitalik Buterin .

The latest funding will be utilized to further the cause of longevity research, as well as to establish VitaDAO 's first biotech venture. The announcement of this landmark step is expected in the opening months of 2023. Moreover, VitaDAO has plans to escalate its efforts in commercializing and legally securing its unique #NFT  intellectual property, in collaboration with Molecule.

Source: BeInCrypto

With the announcement of VitaDAO securing a whopping $4.1 million in funding, the VITA token saw a meteoric rise of 50%. This spike in price showcases the growing fascination and trust in the #DeSci  community and VitaDAO's pivotal place within it.

This is Pfizer's first-ever foray into the world of DAOs, and they're making a bold statement by choosing VitaDAO as their partner. According to VitaDAO's dealflow steward, Laurence Ion , the pharmaceutical giant holds Vita governance tokens through a special purpose vehicle and has even taken part in governance proposals. This move follows Pfizer's previously-announced commitment of $500,000 to VitaDAO, further solidifying their commitment to decentralized science.

In the summer of 2021, tech visionary Balaji Srinivasan took to Twitter  to share his excitement about the future of #longevityResearch . He proclaimed that longevity held the same game-changing potential for traditional medicine as cryptocurrency was doing for traditional finance. Srinivasan also announced that he was ramping up his investments in the longevity space and had a close eye on VitaDAO as a key player:

VitaDAO is at the forefront of a movement known as decentralized science (DeSci), which aims to shake up the traditional science ecosystem and its centralized bodies of research and funding. Instead, DeSci envisions a future where research is funded through crowdfunding and ownership is decentralized. With Pfizer leading the charge and a successful $4.1 million raise, the future of science funding is looking brighter than ever.

How does the fundraising by VitaDAO contribute to The Rise of Decentralized Science causing a Revolution in Research?

Gone are the days of relying solely on centralized institutions for scientific research and collaboration. A new movement is taking hold, one that aims to transform the way we approach science. Welcome to the world of

Decentralized Science Reformation!

This innovative concept centers around utilizing decentralized autonomous organizations (DAOs) to fuel scientific discovery. With this model, researchers from around the world can come together and make decisions collectively, all while breaking free from the constraints of traditional centralized institutions. Thanks to the power of blockchain and decentralized technologies, scientists can now securely and transparently manage their data, knowledge, and funding. Collaboration is easier, funding is more accessible, and findings can be published with unparalleled transparency and security.

No more waiting for approval from a single source. No more limitations on the flow of information. Decentralized Science Reformation is paving the way for a new era of efficient, democratic, and impactful scientific discoveries.

In the traditional scientific ecosystem, research funding and decision-making are centralized through universities, research foundations, and government agencies. But decentralized science, or DeSci, aims to change that. DeSci leverages the power of blockchain and decentralized technologies to create a more efficient, transparent, and democratic way of conducting scientific research.

VitaDAO's decentralized platform allows scientists from around the world to collaborate on research projects and make decisions collectively, without relying on centralized institutions. This leads to a more efficient and effective research process, with the ability to pool resources, share data and knowledge, and coordinate efforts in real time.

Other Players in the Space

Source: Ultra Rare Bio

What’s next?

The investment from prominent investors like Pfizer, who is participating in a DAO for the first time, shows the growing recognition and acceptance of the potential of decentralized science. With more and more funding being directed towards DeSci initiatives, we can expect to see the decentralization of scientific research gain momentum in the near future, leading to a revolution in the way scientific research is conducted.

The funding is also a significant vote of confidence in the technology itself. By investing in the DAOs, these investors are demonstrating their belief in the future of decentralized governance and the potential for this technology to change the way organizations operate. This investment is also likely to lead to an increase in the development and deployment of DAOs, which will further drive the growth of this technology.

In conclusion, the success of VitaDAO's fundraising is a major milestone for the decentralized science movement and a clear sign that DeSci is on the rise, poised to revolutionize the scientific research landscape. This event further cements our vision at DAOstruct - Bloomberg for DAOs  that the companies of tomorrow will be built on blockchain, bringing a new level of transparency and shared ownership to the table. We eagerly anticipate more DAOs receiving funding in the future and how they'll tackle issues with blockchain-based solutions.